The Epidemiology of Primary Biliary Cholangitis in European Countries: A Systematic Review and Meta-Analysis

Overview

Journal Can J Gastroenterol Hepatol

Specialty Gastroenterology

Date 2021 Jul 9

PMID 34239845

Citations 14

Authors

Jakub Gazda

Sylvia Drazilova

Martin Janicko

Peter Jarcuska

Affiliations

Soon will be listed here.

Abstract

Background: Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease with wide ranges of reported incidence and prevalence.

Aim: To map the incidence and prevalence of PBC in European countries from 2000 through 2020.

Methods: Following PRISMA recommendations, we searched the Medline and Scopus databases for studies with information on either the incidence or prevalence of PBC. After data extraction, we used a random-effects model to estimate both the pooled annual incidence rate and pooled point-prevalence rate and performed subgroup analyses to identify components contributing to between-study heterogeneity.

Results: We performed a qualitative and quantitative analysis of 18 studies. The pooled point-prevalence rate was 22.27 cases per 100,000 inhabitants (95% CI: 17.98-27.01), and the pooled annual incidence rate was 1.87 new cases per 100,000 inhabitants (95% CI: 1.46-2.34). In the subgroup analyses, we proved that a small part of the between-study heterogeneity is significantly associated with a history of being part of the Eastern Bloc.

Citing Articles

Factors associated with progression and outcomes of primary biliary cholangitis: A cohort study, 2010-2019.

Sajadi S, Tamizifar B, Sanei M, Babak A J Res Med Sci. 2024; 29:59.

PMID: 39629031 PMC: 11613980. DOI: 10.4103/jrms.jrms_813_22.

Epidemiology of autoimmune liver disease in Korea: evidence from a nationwide real-world database.

Lim J, Kim H Orphanet J Rare Dis. 2024; 19(1):178.

PMID: 38685058 PMC: 11057181. DOI: 10.1186/s13023-024-03086-0.

Primary biliary cirrhosis and psoriasis: a two-sample Mendelian randomization study.

Zhao D, Zhao Q, Xu F, Zhang F, Bai W Front Immunol. 2024; 14:1264554.

PMID: 38239358 PMC: 10794341. DOI: 10.3389/fimmu.2023.1264554.

Sequence of events leading to primary biliary cholangitis.

Lenci I, Carni P, Milana M, Bicaj A, Signorello A, Baiocchi L World J Gastroenterol. 2023; 29(37):5305-5312.

PMID: 37899786 PMC: 10600805. DOI: 10.3748/wjg.v29.i37.5305.

Changing epidemiology of cirrhosis from 2010 to 2019: results from the Global Burden Disease study 2019.

Xiao S, Xie W, Zhang Y, Lei L, Pan Y Ann Med. 2023; 55(2):2252326.

PMID: 37647379 PMC: 10469427. DOI: 10.1080/07853890.2023.2252326.

References

Beretta-Piccoli B, Stirnimann G, Cerny A, Semela D, Hessler R, Helbling B . Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland. Clin Rev Allergy Immunol. 2017; 54(2):295-306. DOI: 10.1007/s12016-017-8656-x. View

Corpechot C, Chazouilleres O, Rousseau A, Le Gruyer A, Habersetzer F, Mathurin P . A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis. N Engl J Med. 2018; 378(23):2171-2181. DOI: 10.1056/NEJMoa1714519. View

Marzioni M, Bassanelli C, Ripellino C, Urbinati D, Alvaro D . Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database. Dig Liver Dis. 2018; 51(5):724-729. DOI: 10.1016/j.dld.2018.11.008. View

Selmi C, Gershwin M . The role of environmental factors in primary biliary cirrhosis. Trends Immunol. 2009; 30(8):415-20. DOI: 10.1016/j.it.2009.05.006. View

Lleo A, Leung P, Hirschfield G, Gershwin E . The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review. Semin Liver Dis. 2019; 40(1):34-48. DOI: 10.1055/s-0039-1697617. View

Lleo A, Jepsen P, Morenghi E, Carbone M, Moroni L, Battezzati P . Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis. Sci Rep. 2016; 6:25906. PMC: 4872151. DOI: 10.1038/srep25906. View

Pla X, Vergara M, Gil M, Dalmau B, Cistero B, Bella R . Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community. Eur J Gastroenterol Hepatol. 2007; 19(10):859-64. DOI: 10.1097/MEG.0b013e328277594a. View

Nevens F, Andreone P, Mazzella G, Strasser S, Bowlus C, Invernizzi P . A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. N Engl J Med. 2016; 375(7):631-43. DOI: 10.1056/NEJMoa1509840. View

Zeng N, Duan W, Chen S, Wu S, Ma H, Ou X . Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis. Hepatol Int. 2019; 13(6):788-799. DOI: 10.1007/s12072-019-09984-x. View

10.

Drazilova S, Babinska I, Gazda J, Halanova M, Janicko M, Kucinsky B . Epidemiology and clinical course of primary biliary cholangitis in Eastern Slovakia. Int J Public Health. 2020; 65(5):683-691. DOI: 10.1007/s00038-020-01391-6. View

11.

. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017; 67(1):145-172. DOI: 10.1016/j.jhep.2017.03.022. View

12.

Jepsen P, Gronbaek L, Vilstrup H . Worldwide Incidence of Autoimmune Liver Disease. Dig Dis. 2015; 33 Suppl 2:2-12. DOI: 10.1159/000440705. View

13.

Madir A, Bozin T, Mikolasevic I, Milic S, Stimac D, Mijic M . Epidemiological and clinical features of primary biliary cholangitis in two Croatian regions: a retrospective study. Croat Med J. 2020; 60(6):494-502. PMC: 6952898. View

14.

Rautiainen H, Salomaa V, Niemela S, Karvonen A, Nurmi H, Isoniemi H . Prevalence and incidence of primary biliary cirrhosis are increasing in Finland. Scand J Gastroenterol. 2007; 42(11):1347-53. DOI: 10.1080/00365520701396034. View

15.

Marschall H, Henriksson I, Lindberg S, Soderdahl F, Thuresson M, Wahlin S . Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort. Sci Rep. 2019; 9(1):11525. PMC: 6687809. DOI: 10.1038/s41598-019-47890-2. View

16.

Ala A, Stanca C, Bu-Ghanim M, Ahmado I, Branch A, Schiano T . Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology. 2006; 43(3):525-31. DOI: 10.1002/hep.21076. View

17.

McNally R, James P, Ducker S, Norman P, James O . No rise in incidence but geographical heterogeneity in the occurrence of primary biliary cirrhosis in North East England. Am J Epidemiol. 2014; 179(4):492-8. PMC: 3908630. DOI: 10.1093/aje/kwt308. View

18.

Rigopoulou E, Davies E, Pares A, Zachou K, Liaskos C, Bogdanos D . Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut. 2005; 54(4):528-32. PMC: 1774444. DOI: 10.1136/gut.2003.036558. View

19.

Gatselis N, Zachou K, Lygoura V, Azariadis K, Arvaniti P, Spyrou E . Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece. Eur J Intern Med. 2017; 42:81-88. DOI: 10.1016/j.ejim.2017.05.006. View

20.

Kouroumalis E . Environmental agents involved in the cause of primary biliary cirrhosis. Dis Markers. 2011; 29(6):329-36. PMC: 3835382. DOI: 10.3233/DMA-2010-0769. View